ClinicalTrials.gg
Not yet recruitingNCT06570304PRINCESSUpdated Jan 15, 2026

Prevention of Retained Items iN Childbirth Environment and Surgical Sites

An observational study in Retained Surgical Items, sponsored by The Royal Wolverhampton Hospitals NHS Trust. Not yet recruiting. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-15.

Sponsored by The Royal Wolverhampton Hospitals NHS Trust · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
30
Ages
18 Years and older
Sex
Female
01

Study summary

To evaluate the user confidence in the confirmation of correct counts using a novel device and to assess clinical usability of the device during surgery.

Read the detailed description

Accidentally retained surgical items or swabs are well-recognised errors that result in adverse consequences for patients. This error is one of the commonest "Never Events" - patient safety incidents that are considered preventable. Although uncommon, these incidents can have devastating consequences. Retained surgical items have 70% re-interventions, reaching 80% morbidity and 35% mortality. (Birolini et al, 2016) 1

Swabs or sponges are like small towels that soak up blood and body fluids so that the surgeon can visualise the operating area effectively. Swabs are used in all areas of surgery which include operations on the tummy, chest, limbs. They are also used in the vagina during childbirth, to assess for tears and to minimise blood oozing from the vagina.

The common risk factors for this error are out of hours surgical or childbirth procedures, multiple handovers in the care of the patient, raised BMI (Body Mass Index) and unplanned change to the operative intervention. (Gawande et al, 2003)2 As the name suggests, a 'never event' should never happen. Unfortunately, incidents involving surgical swabs being left behind, particularly during a caesarean section or a perineal repair following a vaginal birth, are still happening despite over 100 years of institutional awareness of the problem and tentative solutions being implemented in clinical practice.

Never-events involving retained surgical swabs are a widespread problem affecting healthcare systems worldwide. It is therefore reasonable to ask the question: why are surgical swabs being left behind and what can be done to prevent this from happening?

Patient safety is a well-known priority for the European commission, WHO and the NHS. Some of the National/International reports highlighting this problem:

  • CQC-Opening the door to change (2018)
  • US Joint Commission report: Preventing unintended retained foreign objects (2019)
  • The Australian Commission on Safety and Quality in Health Care and The New Zealand Health Quality and Safety Commission (2015)
  • Healthcare Safety Investigation Branch (HSIB,UK) investigation I2018/025 (2019)
02

Conditions studied

  • Retained Surgical Items

Browse trials for

03

In context

Foreign Bodies

29 studies on the registry are indexed under Foreign Bodies; 8 are open to participants now.

This study's planned enrollment of 30 is below the median of 100 across 19 observational studies indexed under Foreign Bodies.

Browse Foreign Bodies studies →

Lead sponsor

The Royal Wolverhampton Hospitals NHS Trust is the lead sponsor of 51 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The participants will be pregnant women during labour.

Staff who work in the operating theatres and are involved in performing swab and instrument counts. Consented to participation after an informed choice.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients due to undergo surgery at the chosen NHS Trust.
  2. Patients 18 years or older and consented to participation after an informed choice.

Exclusion criteria

Exclusion Criteria:

  1. Under 18 years of age
  2. Emergency surgery
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
30 participants (estimated)
Patient registry
No

Groups and cohorts

  • iCount Device

    A novel external device which can count the swabs and surgical tampons used during childbirth in an objective and validated manner.

    Procedure: iCount Device

  • User Feedback Survey

    Anonymised feedback data will be collected from 20 staff users about the user experience and usability of the device. This will be conducted with an online survey questionnaire designed with advice from ergonomics experts after an extensive literature review of human factors-ergonomics principles and MHRA guidance about conducting medical device usability 5 staff users will be randomly selected from the consent forms to have semi-structured interviews developed in accordance with qualitative research methodology for medical device usability testing and user experience.

Interventions

  • ProcedureiCount Device

    Designed as single use. Intended purpose - To be used to count swabs and tampons after surgery in an objective manner. This is intended to be used in patients during and just after surgery. This is a device accessory.

06

What researchers measure

Primary outcomes

  1. Understanding user experience/usability factors

    User responses on Likert scale for the various usability factors such as user confidence in the accuracy of counts, functional aspects and ease of use collected with an online software-assisted survey.

    Time frame: 12 months

  2. How the device sits within the current system

    The purpose is to obtain user centred narratives and a rich qualitative data. Semi-structured interviews of staff will be conducted via a virtual platform or in a safe face-to-face manner. These will be recorded with a dictaphone recording device or Microsoft teams auto-transcription

    Time frame: 12 months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06570304
Lead sponsor
The Royal Wolverhampton Hospitals NHS Trust
Collaborators
Innovate UK
Responsible party
Sponsor
First posted
Aug 26, 2024
Start date
Jun 2026 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Jan 15, 2026

Study contacts

Aditi Desai
Contact
aditidesai@nhs.net
01902695166
Lorraine Jacques
Contact
lorraine.jacques@nhs.net
01902 695065
Aditi Desai
principal investigator · The Royal Wolverhampton NHS Trust

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion